Measles-containing-vaccine second-dose (MCV2) immunization coverage in Latvia

Latvia: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 90.0% in 2025. β–Ό Falling

Latest (2025)
90.0%
Change on year
up 2.3%
World rank
69th
of 192 countries
All-time high
99.0%
in 2005
All-time low
85.0%
in 2021
Years of data
26
2000–2025

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Latvia, 2000–2025

0204060801002000201220252000: 902001: 952002: 962003: 972004: 982005: 992006: 992007: 982008: 942009: 922010: 932011: 922012: 922013: 922014: 892015: 922016: 892017: 892018: 942019: 962020: 942021: 852022: 862023: 922024: 882025: 90

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Latvia is 90.0%, measured in 2025.

Compared with earlier readings it is up 2.3% on the previous year and down 2.2% over ten years.

Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Latvia peaked at 99.0% in 2005 and was at its lowest, 85.0%, in 2021.

That places Latvia 69th out of 192 countries with data for 2025, putting it in the middle of the range.

The long-run direction has been consistently falling across the 26 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
2000s 95.8% 90.0% 99.0% 10
2010s 91.8% 89.0% 96.0% 10
2020s 89.2% 85.0% 94.0% 6

Countries ranked near Latvia

  1. 69 Rwanda 90.0% compare
  2. 69 Jordan 90.0% compare
  3. 72 Malta 89.0% compare
  4. 72 Eritrea 89.0% compare

See the full ranking of 206 places β†’

More health data for Latvia

All data for Latvia β†’

Frequently asked questions

What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Latvia?
Measles-containing-vaccine second-dose (mcv2) immunization coverage in Latvia was 90.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Latvia?
The highest recorded value was 99.0% in 2005.
What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Latvia?
The lowest recorded value was 85.0% in 2021.
How does Latvia rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
Latvia ranks 69th out of 192 countries with data for 2025.
Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Latvia?
Over the last ten years it is down 2.2%. The long-run trend across the full record is falling.
Where does this Latvia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV Β· JSON β€” 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Latvia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 20 August 2026, from https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/latvia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/latvia/">Measles-containing-vaccine second-dose (MCV2) immunization coverage in Latvia</a> β€” Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 5,337 data points, 2000–2025
Last refreshed